[Swiss warmblood horse with symptoms of hereditary equine regional dermal asthenia without mutation in the cyclophylin B gene (PPIB)].

The research focuses on a Swiss Warmblood horse exhibiting symptoms of a genetic skin disease known as Hereditary Equine Regional Dermal Asthenia (HERDA), but interestingly, without the typical associated gene mutation (in the PPIB gene). The common secondary etiological disorders – certain types of Ehlers-Danlos syndrome – were also ruled out in this case.

Research Context

• Hereditary Equine Regional Dermal Asthenia (HERDA) represents a genetic skin disease, primarily affecting Quarter Horses and their related breeds. This disease is marked by symptoms like over-flexibility of the skin and a disposition to bruise quickly, particularly on the animal’s back.
• Affected horses face severe health implications, which often disrupt their typical lifestyles, making normal riding impossible. Thus, many such horses are put down.
• HERDA is usually linked to a mutation in the cyclophilin B (PPIB) gene in Quarter Horses, an enzyme crucial for collagen formation.
• Certain types of Ehlers-Danlos syndrome also commonly present as secondary or etiological diseases in these cases.

Research Findings

• The study presents an atypical case of a Swiss Warmblood filly that displayed HERDA symptoms but was found to be devoid of the mutation in the PPIB gene usually associated with the disorder.
• Moreover, in this particular case, the standard etiological diseases related to skin disorders, such as Ehlers-Danlos syndrome Types: IV, VI, VIIA, VIIB, and VIIC (Dermatosparaxis Type), were also excluded.
• This suggests that there may alternate genetic causes or factors for HERDA, aside from the PPIB gene mutations, at least in Swiss Warmblood horses. The identification of these factors could have significant implications on the understanding and management of HERDA.

Important Implications

• This research highlights the genetic complexity of HERDA and points to the necessity of further investigation to identify other potential genetic causes.
• The findings also underscore the need to expand the genetic screening parameters when diagnosing HERDA, especially in unconventional breeds or cases where the common gene mutation is absent.
• Ultimately, more holistic and diverse genetic research is required to aid in diagnosis, treatment, and potential prevention of HERDA in horses.